Home > Insider Trading > Filing (0001104659-15-007383)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1135906	Epirus Biopharmaceuticals Inc.	EPRS	Pharmaceutical Preparations (2834)	043514457

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219014	M Scott Rocklage	C/O Epirus Biopharmaceuticals, Inc. 699 Boylston Street, 8Th Floor Boston MA 02116		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-04	10,050	$5.00	65,699	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2015-02-04	389,950	$5.00	2,549,211	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Footnotes

Shares directly beneficially owned by 5AM Co-Investors III, L.P.
5AM Partners III, LLC is the general partner of 5AM Ventures III, L.P. and 5AM Co-Investors III, L.P. Dr. John Diekman, Andrew Schwab and Dr. Scott Rocklage are the managing members of 5AM Partners III, LLC. 5AM Partners III, LLC may be deemed to have sole voting and investment power over the shares beneficially owned by 5AM Ventures III, L.P. and 5AM Co-Investors III, L.P. Dr. Diekman, Mr. Schwab and Dr. Rocklage may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM Ventures III, L.P. and 5AM Co-Investors III, L.P. Each of 5AM Partners III, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaim beneficial ownership of such shares, except to the extent of its or their pecuniary interest therein.
Shares directly beneficially owned by 5AM Ventures III, L.P.